ArticleNaunyn-Schmiedeberg's archives of pharmacology2026
Intranasal curcumin mitigates paraquat-induced oxidative lung damage via involvement of neutrophil extracellular traps (NETs) in mice model.
Article in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Paraquat (PQ) is a highly toxic herbicide that causes rapid and severe lung injury via oxidative stress and inflammatory activation. The present study aimed to investigate the protective effects of curcumin on PQ inhalation-induced lung injury in a mice model. Therefore, the intranasal route of PQ administration was selected, where mice were euthanized after 48 h of PQ exposure. Enhanced oxidative damage and the formation of neutrophil extracellular traps were released by activated neutrophils, along with elevated inflammatory mediators. Oxidative stress-induced lung injury was accompanied with increased DNA damage and reduced antioxidant defenses. Lung injury severity was higher with intranasal PQ in terms of inflammatory cell infiltration and early fibrotic changes, with collagen deposition around the bronchioles. Reduced E-cadherin, a marker of epithelial cells, and enhanced α-SMA were noted, showing enhanced epithelial to mesenchymal transition (EMT) in PQ-induced groups, which was reduced in intranasal curcumin treatment groups. Substantially reduced oxidative stress, NF-kB expression, and enhanced Nrf2 levels were noted, indicative of restored antioxidant enzymes and limited inflammatory responses, signifying a protective effect against PQ-induced lung injury. Immunofluorescence and protein expression analysis revealed fibrotic changes in the lungs, where enhanced alpha smooth muscle actin (α-SMA) and MMP9 expressions were reduced with intranasal curcumin treatment.
Indexed as
Identifiers
41656438What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.